Reduced left ventricular contractile reserve identified by low dose dobutamine echocardiography as an early marker of cardiac involvement in asymptomatic patients with thalassemia major

Echocardiography

Volumn 13, Issue 5, 1996, Pages 463-472

  Mariotti, Egidio ^b   Agostini, Alberto ^b   Angelucci, Emanuele ^b   Lucarelli, Guido ^b   Sgarbi, Ernesto ^b   Picano, Eugenio ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b SAN SALVATORE HOSPITAL   (Italy)

Author keywords

dobutamine; echocardiography; hemochromatosis; stress

Indexed keywords

DOBUTAMINE;

ADULT; ARTICLE; BLOOD FLOW VELOCITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE CONTRACTILITY; HEMOCHROMATOSIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; THALASSEMIA MAJOR; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 0029795554     PISSN: 07422822     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8175.1996.tb00922.x     Document Type: Article

References (27)

1. Bunn HF: Disorders of hemoglobin - Thalassemias. In Wilson JD, Braunwald E, Isselbacher KI, et al (eds): Harrison's Principles of Medicine. McGraw Hill, New York, 1991, pp. 1542-1552.
2. Zurlo AR, De Stefano P, Borgna-Pignatti C, et al: Survival and causes of death in thalassemia major. Lancet 1989; II:27-30.
3. Cohen AR, Mizanin J, Schwartz E: Rapid removal of excessive iron with daily high-dose intravenous chelation therapy. J Pediatr 1989; 115:151-155.
4. Lucarelli G, Galimberti M, Polchi P, et al: Bone marrow transplantation in patients with thalassemia. N Engl J Med 1990;322:417-421.
5. Spirito P, Lupi G, Melevendi C, et al: Restrictive diastolic abnormalities identified by Doppler echocardiography in patients with thalassemia major. Circulation 1990;82:88-94.
6. Kremastinos D, Tsiapras DP, Tsetsos GA, et al: Left ventricular diastolic Doppler characteristics in beta-thalassemia major. Circulation 1993;88:1127-1135.
7. Lattanzi F, Bellotti P, Picano E, et al: Quantitative ultrasonic analysis of myocardium in patients with thalassemia major and iron overload. Circulation 1993;87:748-754.
8. Pierard LA, DeLandsheere CM, Berthe C, et al: Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: Comparison with positron emission tomography. JACC 1990;15:1021-1031.
9. Smart SC, Sawada S, Ryan T, et al: Low-dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction. Circulation 1993; 88:405-415.
10. Barilla F, Gheorghiade M, Alam M, et al: Low-dose dobutamine in patients with acute myocardial infarction identifies viable but not contractile myocardium and predicts the magnitude of improvement in wall motion abnormalities in response to coronary revascularization. Am Heart J 1991;122:1522-1531.
11. Moraes A, Graziosi P, Medeiros C, et al: Acute rejection impairs left ventricular contractile reserve of transplanted heart - A dobutamine echocardiographic study. Circulation 1993;88 Suppl):1305.
12. Klewer SE, Goldberg SJ, Donnerstein RL, et al: Dobutamine stress echocardiography: A sensitive indicator of diminished myocardial function in asymptomatic doxorubicin-treated long-term survivors of childhood cancer. JACC 1992;19:394-401.
13. Ryan T: Dobutamine stress echocardiography. Coron Artery Dis 1991;2:552-558.
14. Sahn DJ, De Maria A, Kisslo J, et al: Recommendation regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements. Circulation 1978; 58:1072-1083.
15. Devereux RB, Alonso DR, Lutas EM, et al: Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol 1986;57:450-458.
16. Teichholz LE, Kreulen T, Herman MV, et al: Problems in echocardiographic volume determinations: Echocardiographic-angiographic correlations in the presence or absence of asynergy. Am J Cardiol 1976;37:7-11.
17. Grossman W, Jones D, McLaurin LP: Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest 1975;56:56-64.
18. Brodie BR, McLaurin LP, Grossman W: Combined hemodynamic-ultrasonic method for studying left ventricular wall stress: Comparison with angiography. Am J Cardiol 1976;37: 864-870.
19. Snedecor GW, Cochran WG: Statistical Methods. 8th Ed. Iowa State University Press, Ames, IA, 1989, pp. 55-57.
20. Pierard LA: Pharmacological stress echocardiography. In Roelandt JRTC, Sutherland GR, Iliceto S, et al (eds): Cardiac Ultrasound. Churchill Livingstone, New York, 1993, pp. 505-512.
21. Valdes-Cruz L, Reincenke C, Rutkowski M, et al: Preclinical abnormal segmental cardiac manifestations of thalassemia major in children on transfusion-chelation therapy: Echocardiographic alteration of left ventricular posterior wall contraction and relaxation patterns. Am Heart J 1982;103:505-511.
22. Wolfe L, Olivieri N, Saalan D, et al: Prevention of cardiac disease by subcutaneous deferoxamine in patients with thalassemia major. N Engl J Med 1985;312:1600-1603.
23. Nishimura RA, Housmans PR, Hatle LK, et al: Assessment of diastolic function of the heart: Background and current applications of Doppler echocardiography. Part I. Physiologic and pathophysiologic features. Mayo Clin Proc 1989;64:71-81.
24. Nishimura RA, Abel MD, Hatle LK, et al: Assessment of diastolic function of the heart: Background and current applications of Doppler echocardiography. Part II. Physiologic and pathophysiologic features. Mayo Clin Proc 1989; 64:181-204.
25. Skorton DJ: Noninvasive assessment of myocardial composition and function in the hypertrophied heart. (Editorial) Circulation 1989;80: 1095-1097.
26. Perez JE: Ultrasound characterization of myocardial hypertrophy. (Editorial). JACC 1991; 17:1091-1093.
27. Picano E, Mathias W Jr, Pingitore A, et al, for the EDIC study group: Safety and tolerability of dobutamine-atropine stress echocardiography: A prospective multicentre trial. Lancet 1994;344:1190-1192.